arrow
Back
M

Masanori Atsukawa

Nippon Medical School

39H-index
354Paper Count
5.5KCitation Count
Published Papers 164
Publication Date
Metabolomics Approach Identifies Predictive Serum Markers for Hepatocellular Carcinogenesis Following Hepatitis C Virus Elimination
errCancers
IF4.4
err2026-06-23
err0
errOAAI
errTakeshi Chida; Satoshi Sakai; Masahiko Ito; Kazumasa Sekihara; Kazuyoshi Ohta; Masahiro Matsushita; Gou Murohisa; Fujito Kageyama; Yuzo Sasada; Tatsuki Oyaizu; Minoru Tsugiki; Katsutoshi Tamakoshi; Tomomi Okubo; Sachiyo Yoshio; Masanori Atsukawa; Akihito Tsubota; Yasuhito Tanaka; Tatsuya Kanto; Toshiyuki Ojima; Kazuhito Kawata; Takafumi Suda; Tetsuro Suzuki
errShare
errSave
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions
err2026-06-08
err0
errOAAI
errHidenori Toyoda; Yujin Hoshida; Neehar D. Parikh; Prasun K. Jalal; Federico Piñero; Manuel Mendizabal; Ezequiel Ridruejo; Hugo Cheinquer; Andrea Casadei-Gardini; Mounika Kanneganti; Arndt Weinmann; Markus Peck-Radosavljevic; Jean-Francois Dufour; Pompilia Radu; Gamal Shiha; Riham Soliman; Shiv K. Sarin; Manoj Kumar; Jing-Houng Wang; Pisit Tangkijvanich; Wattana Sukeepaisarnjaroen; Masanori Atsukawa; Haruki Uojima; Akito Nozaki; Makoto Nakamuta; Koichi Takaguchi; Atsushi Hiraoka; Hiroshi Abe; Kentaro Matsuura; Tsunamasa Watanabe; Noritomo Shimada; Kunihiko Tsuji; Toru Ishikawa; Shigeru Mikami; Ei Itobayashi; Philip J. Johnson; Amit G. Singal
errShare
errSave
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models
err2026-05-04
err0
PREAI
errTakashi Kumada; Masanori Atsukawa; Norio Itokawa; Taeang Arai; Hidenori Toyoda; Akihito Tsubota; Tsunamasa Watanabe; Makoto Chuma; Kentaro Matsuura; Atsushi Hiraoka; Toshifumi Tada; Koichi Takaguchi; Keizo Kato; Hiroshi Abe; Joji Tani; Toru Ishikawa; Chikara Ogawa; Toru Asano; Tsunekazu Oikawa; Yoshihiro Matsumoto; Tomoyuki Akita; Junko Tanaka
errShare
errSave
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
err2026-04-21
err0
PREAI
errFujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group
errShare
errSave
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab
err2026-04-10
err0
PREAI
errKazunari Tanaka; Kunihiko Tsuji; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Fujimasa Tada; Hideko Ohama; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real-Life Practice Experts for HCC (RELPEC) Study Group and Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
errShare
errSave
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2–F3 Fibrosis in Japanese Patients With MASLD
err2026-03-12
err0
PREAI
errYuya Seko; Taeang Arai; Hirokazu Takahashi; Hidenori Toyoda; Hideki Hayashi; Kanji Yamaguchi; Michihiro Iwaki; Masato Yoneda; Toshihide Shima; Hideki Fujii; Asahiro Morishita; Kazuhito Kawata; Kengo Tomita; Miwa Kawanaka; Yuichi Yoshida; Tadashi Ikegami; Kazuo Notsumata; Satoshi Oeda; Masanori Atsukawa; Yoshihiro Kamada; Yoshio Sumida; Eiji Miyoshi; Shinichi Aishima; Takeshi Okanoue; Tomohisa Takagi; Atsushi Nakajima
errShare
errSave
Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus Infection
err2026-03-06
err0
PREAI
errHidenori Toyoda; Akito Nozaki; Atsushi Hiraoka; Ei Itobayashi; Haruki Uojima; Hiroshi Abe; Koichi Takaguchi; Masanori Atsukawa; Norio Itokawa; Kentaro Matsuura; Motoyuki Kojima; Toru Ishikawa; Tsunamasa Watanabe; Shigeru Mikami; Kunihiko Tsuji; Hideko Ohama; Fujimasa Tada; Akemi Tsutsui; Tomomi Okubo; Taeang Arai; Makoto Nakamuta; Michitaka Imai; Kazunari Tanaka; Toshifumi Tada; Shinichiro Nakamura; Noritomo Shimada; Takashi Kumada
errShare
errSave
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab
err2026-02-26
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Takashi Nishimura; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Takanori Matsuura; Yoshihide Ueda; Soo Ki Kim; Hideko Ohama; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Shinya Fukunishi; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Jumpei Okamura; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the RELPEC Group and HCC 48 Group
errShare
errSave
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort Study
err2026-02-07
err0
errOAAI
errKaori Koyano; Taeang Arai; Hidenori Toyoda; Keizo Kato; Joji Tani; Suguru Ogura; Tomomi Okubo; Korenobu Hayama; Norio Itokawa; Toshifumi Tada; Akito Nozaki; Atsushi Hiraoka; Kentaro Matsuura; Toru Ishikawa; Naoto Kawabe; Tsunamasa Watanabe; Koichi Takaguchi; Asahiro Morishita; Hironao Okubo; Motoh Iwasa; Hiroki Nishikawa; Yasuhito Tanaka; Masanori Atsukawa
errShare
errSave
Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial
err2025-10-07
err0
errOAAI
errArase, Yoshitaka; Okubo, Tomomi; Arai, Taeang; Abe, Masanori; Namisaki, Tadashi; Uojima, Haruki; Matsumoto, Kosuke; Kakisaka, Keisuke; Setsu, Toru; Mishima, Yusuke; Tsuruya, Kota; Hirose, Shunji; Deguchi, Ryuzo; Shiraishi, Koichi; Atsukawa, Masanori; Ikegami, Tadashi; Honda, Akira; Terai, Shuji; Yoshiji, Hitoshi; Komori, Atsumasa; Tanaka, Atsushi; Kagawa, Tatehiro
errShare
errSave
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs
err2025-10-01
err0
PREAI
errChau, Angela; Li, Jie; Jun, Dae Won; Hsu, Yao-Chun; Toyoda, Hidenori; Yeh, Ming-Lun; Watanabe, Tsunamasa; Honda, Takashi; Trinh, Huy; Nozaki, Akito; Uojima, Haruki; Ishikawa, Toru; Huang, Daniel Q.; Vutien, Philip; Marciano, Sebastian; Abe, Hiroshi; Atsukawa, Masanori; Enomoto, Masaru; Takahashi, Hirokazu; Tsuji, Kunihiko; Takaguchi, Koichi; Itobayashi, Ei; Huang, Rui; Tsai, Pei-Chien; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Yoon, Eileen; Kim, Sung Eun; Ahn, Sang Bong; Kim, Gi-Ae; Jung, Jang Han; Jeong, Soung Won; Oh, Hyunwoo; Hsiao, Tiffany; Maeda, Mayumi; Tseng, Cheng-Hao; Yasuda, Satoshi; Ishigami, Masatoshi; Chuma, Makoto; Ito, Takanori; Kawashima, Keigo; Liu, Joanne Kimiko; Itokawa, Norio; Kozuka, Ritsuzo; Inoue, Kaori; Senoh, Tomonori; Chuang, Wan-Long; Gadano, Adrian; Tanaka, Yasuhito; Lim, Seng Gee; Wu, Chao; Cheung, Ramsey; Yu, Ming-Lung; Nguyen, Mindie H.
errShare
errSave
Clinical Utility of a Prognostic Scoring System Based on LDH and CRP in HCC Patients Receiving Atezolizumab Plus Bevacizumab
err2025-09-19
err0
PREAI
errTanaka, Kazunari; Tsuji, Kunihiko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Ishikawa, Toru; Tajiri, Kazuto; Ohama, Hideko; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Kanayama, Yuki; Tada, Fujimasa; Nakamura, Shinichiro; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Tanaka, Hironori; Noritake, Hidenao; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi
errShare
errSave
Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis
err2025-09-06
err0
PREAI
errHatanaka, Takeshi; Yata, Yutaka; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Kakizaki, Satoru; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Matsui, Kosuke; Naganuma, Atsushi; Tanaka, Hironori; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Ochi, Hironori; Imai, Michitaka; Nakamura, Shinichiro; Komatsu, Shohei; Tamai, Hideyuki; Okamura, Jumpei; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Matsuura, Takanori; Noritake, Hidenao; Enomoto, Hirayuki; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi
errShare
errSave
Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma
err2025-08-20
err0
PREAI
errHideko Ohama; Atsushi Hiraoka; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Hideyuki Tamai; Shohei Komatsu; Fujimasa Tada; Shinichiro Nakamura; Yoshiko Nakamura; Teruki Miyake; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Takanori Matsuura; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada
errShare
errSave
Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis
err2025-08-06
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Hiroki Nishikawa; Kazunari Tanaka; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Yuichi Koshiyama; Hidenori Toyoda; Chikara Ogawa; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Hidenao Noritake; Hideko Ohama; Fujimasa Tada; Kazuhiro Nouso; Asahiro Morishita; Akemi Tsutsui; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Takashi Nishimura; Michitaka Imai; Hisashi Kosaka; Atsushi Naganuma; Tomoko Aoki; Hidekatsu Kuroda; Yutaka Yata; Hideyuki Tamai; Takanori Matsuura; Shohei Komatsu; Yoshihide Ueda; Yoshiko Nakamura; Osamu Yoshida; Kosuke Matsui; Shinichiro Nakamura; Hirayuki Enomoto; Masaki Kaibori; Takumi Fukumoto; Yoichi Hiasa; Masatoshi Kudo; the Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group
errShare
errSave
Vascular Invasion Within the Resectability Criteria Is a Prognostic Factor in Patients Treated With Atezolizumab and Bevacizumab
err2025-07-07
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi
errShare
errSave
Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus
err2025-07-05
err0
errOAAI
errTaeang Arai; Masanori Atsukawa; Chikako Nagao; Zento Yamada; Takahiro Rokugo; Kenta Suzuki; Michika Kitamura; Tetsuyuki Higashi; Kaori Koyano
errShare
errSave
Neutrophil–Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab
err2025-06-14
err0
PREAI
errTomomitsu Matono; Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi
errShare
errSave
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study
err2025-05-21
err0
PREAI
errHuang, R; Do, A; Toyoda, H; Li, J; Yasuda, S; Tsai, PC; Yeh, ML; Trinh, H; Chau, A; Huang, DQ; Ogawa, E; Ito, T; Kozuka, R; Atsukawa, M; Marciano, S; Honda, T; Watanabe, T; Itokawa, N; Preda, CM; Tseng, CH; Barreira, A; Inoue, K; Takahashi, H; Uojima, H; Kawashima, K; Hsu, YC; Marin, RI; Sandra, I; Ishigami, M; Li, JY; Zhang, J; Do, S; Maeda, M; Lee, DH; Chuang, WL; Dai, CY; Huang, JF; Huang, CF; Cheung, R; Buti, M; Tanaka, Y; Yuen, MF; Enomoto, M; Gadano, A; Lim, SG; Yu, ML; Wu, C; Nguyen, MH
errShare
errSave